VedaBio Appoints G. Brett Robb, Ph.D., as Senior Scientific Director and Head of CRISPR Science
Slice of Healthcare Team
Sep 06, 2024
Key Highlights
- VedaBio appoints G. Brett Robb, Ph.D., as Senior Scientific Director and Head of CRISPR Science.
- Dr. Robb brings 16 years of R&D expertise in CRISPR-Cas systems, enzyme tools, and RNA biology.
- Dr. Robb previously led CRISPR-Cas efforts at New England Biolabs (NEB).
- His role at VedaBio will drive the commercialization of CRISPR-based molecular detection.
Source: Business Wire
Notable Quotes
“ We are fortunate to have the chance to welcome Brett to the VedaBio team as Senior Scientific Director and Head of CRISPR Science. ”
Frédéric Sweeney, Ph.D., President and CEO at VedaBio
“ VedaBio’s CRISPR cascade uniquely removes the need for nucleic acid pre-amplification... expanding possibilities for diagnostic testing. ”
G. Brett Robb, Ph.D., Senior Scientific Director and Head of CRISPR Science at VedaBio
